Cyveen Weerarantha | Digital Health and Computational Biology | Research Excellence Award

Published on by Computational Biologists

Research Excellence Award

Cyveen Weeraratna
Affiliation Royal Melbourne Hospital
Country Australia
Scopus ID 56151709400
Documents 4
Citations 70
h-index 3
Subject Area Digital Health and Computational Biology
Event Computational Biologists Awards
ORCID 0009-0000-6689-4623

Cyveen Weeraratna
Royal Melbourne Hospital

Cyveen Weerarantha is affiliated with the Royal Melbourne Hospital, Australia, and has contributed to research spanning digital health and computational biology. The Research Excellence Award recognizes scholarly achievements that demonstrate scientific quality, interdisciplinary collaboration, and measurable research influence. Within this context, the researcher represents an emerging contributor whose published work, citation record, and involvement in computational health research align with the objectives of academic recognition and professional excellence.[1]

Abstract

The Research Excellence Award recognizes investigators whose scholarly activities demonstrate sustained scientific quality, meaningful research impact, and contributions to advancing knowledge within their discipline. Cyveen Weerarantha’s academic profile reflects involvement in digital health and computational biology through publications that support data-driven healthcare research and interdisciplinary collaboration. Bibliometric indicators, including publications, citations, and an established h-index, provide measurable evidence of scholarly engagement. These achievements, combined with institutional affiliation and participation in computational health research, illustrate an emerging academic profile consistent with the principles of excellence, innovation, research integrity, and professional contribution.[1][2]

Keywords

Digital Health, Computational Biology, Biomedical Informatics, Clinical Research, Health Data Analytics, Research Excellence, Scientific Impact, Translational Medicine.

Introduction

Digital health and computational biology continue to reshape biomedical research by integrating advanced computational techniques with clinical practice and biological sciences. Researchers working within these domains contribute to improved diagnostic methodologies, health data interpretation, and evidence-based decision making. Recognition through research awards reflects scientific productivity together with ethical scholarship, interdisciplinary collaboration, and measurable academic influence within evolving healthcare environments.[2]

Research Profile

Cyveen Weerarantha is associated with the Royal Melbourne Hospital in Australia and maintains an indexed publication record within Scopus. Research activities emphasize computational approaches supporting healthcare research, reflecting collaboration across clinical and data science disciplines. Bibliometric indicators demonstrate developing academic influence supported by published literature and citation performance that contributes to ongoing scientific communication and knowledge dissemination.[1]

Research Contributions

The research contributions associated with this profile emphasize computational analysis applied to healthcare challenges, integrating biological information with digital technologies to improve research methodologies. Such work supports evidence generation, promotes interdisciplinary collaboration, and contributes to broader understanding of data-driven healthcare solutions. These efforts reflect the growing importance of computational biology in modern clinical research and biomedical innovation.[3]

Publications

The researcher has four indexed publications that collectively contribute to the scientific literature within digital health and computational biology. Citation activity demonstrates continuing academic visibility, while publication in peer-reviewed venues supports knowledge exchange and encourages future collaborative investigations. Published studies provide a measurable foundation for evaluating research productivity and scholarly engagement within the discipline.[1]

Research Impact

Research impact is commonly evaluated through publication quality, citation performance, scholarly visibility, and contribution to advancing scientific understanding. The available bibliometric indicators demonstrate meaningful engagement with the academic community, while interdisciplinary research strengthens the relevance of computational approaches within healthcare. Such measurable outcomes support recognition through professional and institutional award programs.[4]

Award Suitability

The Research Excellence Award acknowledges researchers demonstrating scientific rigor, measurable scholarly achievement, and continuing contributions to their academic field. Cyveen Weerarantha’s publication record, citation metrics, institutional affiliation, and research focus within computational biology and digital health collectively align with the evaluation principles commonly applied to emerging research excellence awards, emphasizing quality, collaboration, and sustained scholarly development.[1][4]

Conclusion

Cyveen Weerarantha’s scholarly profile illustrates an emerging contribution to computational biology and digital health supported by indexed publications, citations, and interdisciplinary collaboration. These characteristics reflect academic engagement that is consistent with the objectives of the Research Excellence Award, recognizing research quality, scientific integrity, and the advancement of evidence-based healthcare through computational innovation.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Cyveen Weerarantha, Author ID 56151709400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56151709400
  2. American Journal of Kidney Diseases. (2018). Attempts to Change the Globally Accepted Term, CKDu, to KDUCAL, NUCAL, or CINAC Are Inappropriate..
    https://doi.org/10.1053/j.ajkd.2018.01.033
  3. Critical Care and Resuscitation. (2026). Sustainable continuous renal replacement therapy: The influence of blood flow rates, effluent dose, autoeffluent, and citrate anticoagulation on carbon dioxide emissions.
    https://doi.org/10.1016/j.ccrj.2026.100176
  4. Computational Biologists Awards. Research Excellence Award.
    https://computationalbiologists.com/

Afrah Shaahid | Computational Systems Medicine | Research Excellence Award

Published on by Computational Biologists

Ms. Afrah Shaahid | Computational Systems Medicine | Research Excellence Award

KFUPM | Saudi Arabia

Ms. Afrah Shaahid is an emerging AI Developer and researcher with over three years of experience in computer science, specializing in machine learning, deep learning, and computer vision. Currently pursuing a Master’s degree at King Fahd University of Petroleum and Minerals, she has developed advanced AI models including CNNs, GANs, diffusion models, and vision-language systems. Her work spans healthcare, cybersecurity, and image enhancement, with contributions to high-impact research and publications. Afrah has also led workshops, mentored students, and collaborated on multidisciplinary projects. With strong technical expertise and a passion for innovation, she is dedicated to building scalable AI solutions and advancing intelligent systems for real-world applications.

Citation Metrics (Scopus)

400
300
200
100
 0

Citations
173
Documents
4
h-index
4

Citations

Documents

h-index


View Scopus Profile View Orcid Profile View Google Scholar Profile

Featured Publications

Prof Susana Constantino Rosa Santos | Wound healing | Best Researcher Award 

Published on by Computational Biologists

Prof Susana Constantino Rosa Santos | Wound healing | Best Researcher Award 

University of Lisbon Faculty of Medicine | Portugal

Susana Constantino Rosa Santos is a prominent biomedical scientist whose research integrates angiogenesis, vascular regeneration, radiobiology, and translational oncology. Her work has advanced understanding of how low-dose ionizing radiation modulates tissue microenvironments, reprograms metastatic niches, and influences cardiovascular and stromal cell responses. She has led multidisciplinary research efforts that uncover radiation-induced mechanisms driving angiogenesis, cardiac remodeling, and tumor progression, while also identifying molecular markers that predict therapy-related cardiac dysfunction. Her contributions span experimental models, imaging-based functional assessments, biomarker discovery, and cell-based regenerative strategies, establishing new therapeutic and diagnostic perspectives. Widely recognized for her scientific leadership, she contributes to international expert groups evaluating radiation effects and shaping evidence-based guidance for radiation health protection. Her publication record reflects influential findings in endothelial biology, metastatic signaling, fibroblast activation, and immune–stromal interactions. Through competitive research funding and active participation in European collaborative programs, she has advanced cross-disciplinary approaches linking fundamental mechanisms with clinical translation. Her work continues to drive innovation in radiation-responsive tissue repair, vascular therapeutics, and personalized strategies to mitigate radiotherapy-associated toxicity.

Profile: Orcid

Publications

Low-dose ionizing radiation in vivo unlocks the therapeutic potential of prevascularized dermal spheroids in chronic wounds. (2025). Materials Today Bio.

Subtherapeutic dose of ionizing radiation reprograms the pre-metastatic lung niche, accelerating its formation and promoting metastasis. (2025). International Journal of Molecular Sciences.

Cardiac MRI–based subclinical cardiac dysfunction during 2 years after breast cancer irradiation: The MEDIRAD EARLY-HEART study. (2025). Radiology: Cardiothoracic Imaging.

Growth differentiation factor 15 as a biomarker for risk stratification in the cardiothoracic surgery intensive care unit. (2024). Biomolecules.

Multifunctional nanovaccine sensitizes breast cancer to immune checkpoint therapy. (2024). Advanced Functional Materials.

Early impairment of paracrine and phenotypic features in resident cardiac mesenchymal stromal cells after thoracic radiotherapy. (2024). International Journal of Molecular Sciences.

 

Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Published on by Computational Biologists

Prof. Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Professor at Xiamen University, China

Dr. Weiling He is a leading figure in precision oncology, serving as Chief Physician, Professor, Doctoral and Postdoctoral Supervisor, and President of Xiang’an Hospital at Xiamen University. He is widely recognized for his contributions to cancer treatment, particularly in the domains of tumor microenvironments and drug resistance. Honored with the National Natural Science Foundation of China’s Excellent Young Scientist Fund and recognized as a Distinguished Young Medical Talent of Guangdong Province, Dr. He has established himself as a trailblazer in translational medical research. His prolific output includes over 50 SCI-indexed publications and six granted patents, underscoring his influence in both academia and clinical application.

Profile

Scopus

Education

Dr. He holds both an MD and a PhD, equipping him with a robust foundation for navigating the complex landscape of cancer research and treatment. His academic journey reflects a commitment to scientific excellence and multidisciplinary learning, enabling him to bridge the gap between theoretical research and clinical practice. The integration of medicine and scientific inquiry during his training shaped his ongoing work in precision medicine, translational oncology, and systems biology.

Experience

With a career marked by leadership and innovation, Dr. He currently serves as the President of Xiang’an Hospital at Xiamen University. He has led more than 20 research projects at the national and provincial levels, including prestigious programs under the National Key R&D Initiative and the National Natural Science Foundation of China. Dr. He has also contributed extensively to industry-academia collaboration, participating in strategic projects like the Guangdong Soft Science Program and the Guangzhou Future Industry Initiative. His academic affiliations include leadership roles in over ten national medical associations, reflecting a deep engagement with both clinical and academic ecosystems.

Research Interest

Dr. He’s research focuses on unraveling the mechanisms of tumor drug resistance, exploring metastasis pathways, and analyzing the tumor microenvironment. He is particularly interested in precision interventional therapy and the development of biomaterials and microfluidic technologies for real-time monitoring and treatment. His interdisciplinary approach combines oncology, engineering, and systems biology to improve the outcomes of metastatic cancer therapies. Through collaborative research with institutions such as Sun Yat-sen University and Emory University, he advances new methodologies in clinical translation and integrative cancer treatment.

Award

Dr. Weiling He has received several distinguished honors throughout his career. Among them, the National Natural Science Foundation of China awarded him the Excellent Young Scientist Fund, recognizing his outstanding potential and research impact in oncology. In addition, he was named a Distinguished Young Medical Talent of Guangdong Province, affirming his influence on medical innovation and leadership. His work is frequently acknowledged in national and international forums, and he has played a pivotal role in advancing precision medicine initiatives across China.

Publication

Dr. He has authored more than 50 papers indexed in SCI journals, with several appearing in top-tier publications. Notable recent works include:

“Immune Microenvironment Remodeling in Colorectal Cancer,” Cancer Immunology Research, 2020 – cited 326 times.

“Dual Nanoparticle Delivery in Precision Oncology,” Advanced Science, 2021.

“Microfluidic Chips for Real-time Tumor Monitoring,” Nature Communications, 2022.

“Translational Biomaterials in Interventional Therapy,” Science Translational Medicine, 2023 (cover article).

“Integrated Oncology Systems for Drug Resistance,” Nature Cancer, 2023.

“Microsphere Technology for Metastatic Cancer,” Advanced Science, 2024.

“Tumor Sensitization Targets for Interventional Therapy,” Nature Communications, 2024.

These publications have garnered over 1000 citations in total, with multiple works recognized as “Highly Cited Papers” in their respective fields.

Conclusion

Dr. Weiling He’s exceptional academic record, impactful research, numerous high-impact publications, robust patent portfolio, and her pivotal role in the advancement of precision oncology mark her as a standout candidate for the Best Researcher Award. Her commitment to interdisciplinary innovation and translational impact makes her not only deserving of this honor but a role model for future generations in computational and medical biology.

Eyachew Misganew Tegaw | AI in Personalized Medicine | Best Researcher Award

Published on by Computational Biologists

Assist. Prof. Dr. Eyachew Misganew Tegaw | AI in Personalized Medicine | Best Researcher Award

Assistant Professor of Medical Physics at  Debre Tabor University, Ethiopia.

Dr. Eyachew Misganew Tegaw is an Assistant Professor of Medical Physics at Debre Tabor University, Ethiopia. He earned his Ph.D. from Tehran University of Medical Sciences, specializing in intraoperative radiotherapy using nanoparticles for breast cancer treatment. His research spans medical imaging, radiation therapy, nanomedicine, and AI applications in oncology. Dr. Eyachew Misganew Tegaw has published extensively in peer-reviewed journals and actively contributes to scientific advancement through research, mentorship, and international collaboration.

👨‍🎓 Educational Background:

Eyachew Misganew Tegaw holds a Ph.D. in Medical Physics from the Tehran University of Medical Sciences (TUMS), Iran, where he specialized in intraoperative radiotherapy (IORT) using nanoparticles for breast cancer treatment. His academic journey began with a B.Sc. in Applied Physics from the University of Gondar, followed by an M.Sc. in Condensed Matter Physics from Mekelle University. Across these programs, he built a strong foundation in quantum mechanics, computational physics, and radiation therapy physics, gaining multidisciplinary expertise in both theoretical and applied domains.

Profile:

👨‍🏫 Professional Experience:

With over a decade of academic service, Dr. Eyachew Misganew Tegaw currently serves as an Assistant Professor in the Department of Physics at Debre Tabor University, Ethiopia. He previously held the position of Lecturer at the same institution, actively contributing to curriculum development and student mentorship. His leadership experience includes a two-year term as Department Head and three years as Chair of the Ethiopian Space Science Society (Debre Tabor Branch), showcasing his commitment to both academic and community development.

🧪 Research Interests:

Dr. Eyachew Misganew Tegaw is a highly driven researcher with diverse interests spanning medical physics, radiotherapy technologies, medical imaging, radiation dosimetry, nanomedicine, Monte Carlo simulations, and artificial intelligence. His work integrates cutting-edge approaches like deep learning and machine learning with traditional medical physics techniques, aiming to enhance cancer treatment planning and medical imaging. He is especially passionate about nanoparticle-enhanced therapies and computational modeling for improved patient outcomes in oncology.

🔍 Areas for Improvement:

While Dr. Eyachew Misganew Tegaw has made significant strides in academic research, increased visibility through invited talks, expanded international partnerships, and higher engagement in translational clinical projects could further enhance his research impact. Diversifying funding sources and mentoring emerging researchers may also solidify his standing in the global scientific community.

📚 Scientific Contributions

Dr. Eyachew has authored and co-authored numerous peer-reviewed journal articles in high-impact scientific journals. His publications cover a wide range of topics such as Monte Carlo simulations for radiotherapy, nanoparticle-enhanced imaging and treatment, and explainable AI in oncology. Notable among his recent works is a 2025 article in Scientific Reports comparing survival outcomes in breast cancer surgery, and another accepted paper focusing on AI for lung cancer survival prediction. His systematic reviews and meta-analyses have also significantly contributed to evidence-based practice in cancer diagnosis and therapy.

Publications:

  1. Diagnostic performance of mammography and ultrasound in breast cancer: A systematic review and meta-analysis
    Journal of Ultrasound, 2023

  2. Dosimetric characteristics of the INTRABEAM® system with spherical applicators in the presence of air gaps and tissue heterogeneities
    Radiation and Environmental Biophysics, 2020

  3. Techniques for generating attenuation map using cardiac SPECT emission data only: A systematic review
    Annals of Nuclear Medicine, 2019

  4. Molecular imaging approaches in the diagnosis of breast cancer: A systematic review and meta-analysis
    Iranian Journal of Nuclear Medicine, 2020

  5. Comparison of organs at risk doses between deep inspiration breath-hold and free-breathing techniques during radiotherapy of left-sided breast cancer: A meta-analysis
    Polish Journal of Medical Physics and Engineering, 2022

  6. Gold-nanoparticle-enriched breast tissue in breast cancer treatment using the INTRABEAM® system: A Monte Carlo study
    Radiation and Environmental Biophysics, 2022

  7. Dosimetric effect of nanoparticles in the breast cancer treatment using INTRABEAM® system with spherical applicators in the presence of tissue heterogeneities: A Monte Carlo study
    Biomedical Physics & Engineering Express, 2021

  8. A comparison between EGSnrc/Epp and MCNP in simulation of dosimetric parameters for radiotherapy applications
    Journal of Biomedical Physics & Engineering, 2021

  9. Explainable machine learning to compare the overall survival status between patients receiving mastectomy and breast conserving surgeries
    Scientific Reports, 2025

  10. Attenuation correction for dedicated cardiac SPECT imaging without using transmission data
    Molecular Imaging and Radionuclide Therapy, 2023

  11. Comparative study between EPID and CBCT for radiation treatment verifications
    Iranian Journal of Medical Physics, 2018